LGC
ABBV icon

Laurel Grove Capital’s AbbVie ABBV Stock Holding History

Laurel Grove Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30,182
Closed -$2.8M – 94
2018
Q2 		$2.8M Buy
30,182
+1,250
+4% +$122K 1.48% 24
2018
Q1 		$2.74M Sell
28,932
-150
-0.5% -$16.5K 1.47% 25
2017
Q4 		$2.81M Sell
29,082
-1,150
-4% -$108K 1.46% 22
2017
Q3 		$2.69M Sell
30,232
-2,000
-6% -$152K 1.4% 23
2017
Q2 		$2.34M Hold
32,232
– – 1.24% 27
2017
Q1 		$2.1M Sell
32,232
-750
-2% -$47.2K 1.11% 32
2016
Q4 		$2.06M Buy
32,982
+282
+0.9% +$17.2K 1.13% 31
2016
Q3 		$2.06M Sell
32,700
-150
-0.5% -$9.71K 1.18% 29
2016
Q2 		$2.03M Sell
32,850
-650
-2% -$39.6K 1.22% 32
2016
Q1 		$1.91M Sell
33,500
-200
-0.6% -$11.1K 1.09% 34
2015
Q4 		$2M Sell
33,700
-200
-0.6% -$11.5K 1.12% 35
2015
Q3 		$1.84M Hold
33,900
– – 1.06% 37
2015
Q2 		$2.28M Sell
33,900
-200
-0.6% -$13.1K 1.21% 32
2015
Q1 		$2M Buy
34,100
+1,175
+4% +$71K 1.07% 35
2014
Q4 		$2.15M Sell
32,925
-3,900
-11% -$246K 1.23% 30
2014
Q3 		$2.13M Buy
36,825
+100
+0.3% +$5.55K 1.16% 35
2014
Q2 		$2.07M Buy
36,725
+675
+2% +$35.4K 1.15% 35
2014
Q1 		$1.85M Sell
36,050
-1,200
-3% -$60.6K 1.11% 35
2013
Q4 		$1.97M Buy
37,250
+50
+0.1% +$2.46K 1.16% 32
2013
Q3 		$1.66M Sell
37,200
-2,900
-7% -$129K 1.1% 33
2013
Q2 		$1.66M Buy
+40,100
New +$1.75M 1.18% 29

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Laurel Grove Capital's ABBV Position: Q3 2018 in Review

Laurel Grove Capital sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 30,182 shares — an estimated $2.8M sold.

Laurel Grove Capital first reported a position in ABBV in Q2 2013 and held it in 21 quarters. The position peaked at $2.81M in Q4 2017. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Laurel Grove Capital reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Laurel Grove Capital sold 30,182 AbbVie shares in Q3 2018, an estimated $2.8M.
  • Laurel Grove Capital first reported a position in AbbVie in Q2 2013 and held it in 21 quarters.
  • Laurel Grove Capital's AbbVie position peaked at $2.81M in Q4 2017.
  • 1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Laurel Grove Capital's 13F filing for Q3 2018, filed 12 Oct 2018.